中文

三鑫医疗 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-27
ItemAmountY/Y
Revenue¥0.41B+13.4%
Gross profit¥0.15B
Operating income¥0.09B
Net income¥0.08B+27.0%
Gross margin37.1%Net margin 18.4%
Revenue Q/Q-13.5%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.26B62.9%
R&D¥0.02B4.4%
SG&A¥0.05B11.3%
Tax & other¥0.01B2.9%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

深信服航天智装赛微电子赢合科技全志科技汤姆猫ST惠伦田中精机ST华铭迈克生物星徽股份高伟达

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies